BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6734813)

  • 1. [Antitoxic action of cobamamide in experimental hepatitis].
    Tebenchuk GM; Lukashuk VD; Lipkan GN; Stepanenko VV
    Farmakol Toksikol; 1984; 47(3):87-90. PubMed ID: 6734813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental study of the hepatoprotective properties of phytoecdysteroids and nerobol in carbon tetrachloride-induced liver lesion].
    Syrov VN; Khushbaktova ZA; Nabiev AN
    Eksp Klin Farmakol; 1992; 55(3):61-5. PubMed ID: 1458171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antioxidant regulation of the changes in liver excretory function in toxic hepatitis].
    Vinogradova LF; Mirzoian ZhA
    Eksp Klin Farmakol; 1993; 56(5):50-2. PubMed ID: 8312814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The anticytolytic activity of ubiquinone-10 in a liver lesion from chlorinated hydrocarbons].
    Vinogradova LF; Kharlitskaia EV; Mirzoian ZhA; Beketova TP; Burobina SS
    Eksp Klin Farmakol; 1994; 57(6):54-7. PubMed ID: 7756966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New data on the protective action of aspartic acid in experimental toxic hepatitis, assessed by the determination of blood and tissue enzymes of the liver].
    Fodor O; Parau N; Calu C; Ban A
    Rev Int Hepatol; 1965; 15(6):1131-46. PubMed ID: 5854655
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of streptokinase on the hemostatic indices of rabbits with a toxic lesion of the liver due to carbon tetrachloride].
    Nikandrov VN; Naumovich SA; Votiakov VI
    Biull Eksp Biol Med; 1987 Feb; 103(2):159-61. PubMed ID: 3814794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anti-hepatotoxic effect of aliphatic and heterocyclic mercapto compounds in CCl4-induced liver damage in the rat. I].
    Rauen HM; Schriewer H; Fels H
    Arzneimittelforschung; 1973 Jan; 23():Suppl:136-40. PubMed ID: 4740680
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of eplir on an experimental toxic lesion of the liver].
    Saratikov AS; Vengerovskiĭ AI; Paul's OV; Sedykh IM
    Farmakol Toksikol; 1990; 53(5):42-5. PubMed ID: 2253748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of hepatoprotective agents in experimental chronic hepatitis].
    Saratikov AS; Vengerovskiĭ ; Baturina NO; Chuchalin VS
    Eksp Klin Farmakol; 1996; 59(1):24-6. PubMed ID: 8704626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of galbanic acid on the course of experimental hepatitis].
    Syrov VN; Khushbaktova ZA; Nabiev AN
    Farmakol Toksikol; 1990; 53(2):41-3. PubMed ID: 2369953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The anti-hepatotoxic effect of aliphatic and heterocyclic mercapto compounds in CCl4-induced liver damage in the rat. II].
    Rauen HM; Schriewer H; Fels H
    Arzneimittelforschung; 1973 Jan; 23():Suppl:141-5. PubMed ID: 4740681
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of splenin on bromsulphalein metabolism and excretion and bile secretion in rats with toxic hepatitis].
    Oleĭnik BV
    Fiziol Zh; 1978; 24(1):52-6. PubMed ID: 627291
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of essential phospholipids following acute experimental CCl4 liver injury].
    Rauen HM; Schriewer H; Gebauer B; Abu Tair M
    Arzneimittelforschung; 1973 Sep; 23(9):1332-4. PubMed ID: 4801231
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacodynamics, site and mechanism of action of silymarin, the antihepatoxic principle from Silybum mar. (L) Gaertn. 1. Acute toxicology or tolerance, general and specific (liver-) pharmacology].
    Vogel G; Trost W; Braatz R; Odenthal KP; Brüsewitz G; Antweiler H; Seeger R
    Arzneimittelforschung; 1975 Jan; 25(1):82-9. PubMed ID: 1173772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of the marker liver enzymes under the conditions of toxic hepatitis and alimentary deprivation of protein].
    Voloshchuk ON; Kopyl'chuk GP; Buchkovskaia IM
    Eksp Klin Gastroenterol; 2014; (8):96-100. PubMed ID: 25911920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of parameters used to assess liver damage in sheep treated with carbon tetrachloride.
    Alemu P; Forsyth GW; Searcy GP
    Can J Comp Med; 1977 Oct; 41(4):420-7. PubMed ID: 922559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental antioxidant therapy in toxic liver damage from CCl4 and chloxyl].
    Vinogradova LF; Mirzoian ZhA; Kharlitskaia EV; Beketova TP
    Patol Fiziol Eksp Ter; 1989; (4):52-6. PubMed ID: 2556682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PGI2 in carbon tetrachloride-induced liver injury.
    Ujhelyi E; Divald A; Vajta G; Jeney A; Lapis K
    Acta Physiol Hung; 1984; 64(3-4):425-30. PubMed ID: 6397970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characteristics of the action of polyphytochol on the course of experimental hepatitis and cholecystitis].
    Ubeeva IP; Sambueva ZG; Azhunova TA; Nikolaev SM
    Farmakol Toksikol; 1990; 53(2):43-5. PubMed ID: 2369954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antihepatotoxic effect of silymarin on liver damage in rats induced by carbon tetrachloride, d-galactosamine and allyl alcohol].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1971 Aug; 21(8):1194-201. PubMed ID: 5110018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.